Compounders Research Compare

Hyperfine, Inc.(HYPR)

Medical - Devices · Guilford, CT

$0.91+0.02 (+2.71%)

Delayed quote: Oct 6, 2026, 1:30 PM EDT

About Hyperfine, Inc.

Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, and New Zealand. The company was founded in 2014 and is based in Guilford, Connecticut.

Guilford, CT

102 employees

www.hyperfinemri.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Maria Degois Sainz

View full financials

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T17:32:18.788Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:32:18.788Z.

Quote observation: 2026-10-06T17:30:06.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 76,366,206
Total debt · period ending 2026-06-30: 13,413,000
Cash · period ending 2026-06-30: 43,458,000
TTM operating EBITDA · period ending 2026-06-30: -31,809,000

FMP input reference: 48f0cd224d3c7dd52ecd2cde696dbbeed4cc913852df97ed5052446ca25b90ee

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

HYPR EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

HYPR Competitors' EV/EBITDA Ratio

Hyperfine, Inc.

Current

Market Cap

$76.37M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SkinHealth Systems Inc.

Market Cap

$75.91M

EV/EBITDA Ratio

10.31x

TTM Avg

27.31x

3Y Avg

27.31x

5Y Avg

27.31x

Outset Medical, Inc.

Market Cap

$75.09M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Pulmonx Corporation

Market Cap

$77.08M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Sera Prognostics, Inc.

Market Cap

$77.53M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Neonc Technologies Holdings, Inc.

Market Cap

$78.31M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Inovio Pharmaceuticals, Inc.

Market Cap

$78.07M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Citius Oncology, Inc.

Market Cap

$79.96M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Nutriband Inc.

Market Cap

$80.23M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Gain Therapeutics, Inc.

Market Cap

$71.23M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Hyperfine, Inc. (HYPR)	$76.37M	N/A	N/A	N/A	N/A
SkinHealth Systems Inc. (SKIN)vs ›	$75.91M	10.31x	27.31x	27.31x	27.31x
Outset Medical, Inc. (OM)vs ›	$75.09M	N/A	N/A	N/A	N/A
Pulmonx Corporation (LUNG)vs ›	$77.08M	N/A	N/A	N/A	N/A
Sera Prognostics, Inc. (SERA)vs ›	$77.53M	N/A	N/A	N/A	N/A
Neonc Technologies Holdings, Inc. (NTHI)vs ›	$78.31M	N/A	N/A	N/A	N/A
Inovio Pharmaceuticals, Inc. (INO)vs ›	$78.07M	N/A	N/A	N/A	N/A
Citius Oncology, Inc. (CTOR)vs ›	$79.96M	N/A	N/A	N/A	N/A
Nutriband Inc. (NTRB)vs ›	$80.23M	N/A	N/A	N/A	N/A
Gain Therapeutics, Inc. (GANX)vs ›	$71.23M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics